The Jurisdictional Wars: Alliance Theory and the Battle for Power at UCLA Medical School

High-status actors at UCLA’s David Geffen School of Medicine do not compete for authority by openly saying they want power. They compete by invoking moral languages that frame their authority as protecting patients, widening access to care, advancing medical excellence, and serving California’s population. This is the core insight of David Pinsof’s Alliance Theory. Moral vocabularies are coalition technologies. They recruit allies, define legitimacy, and justify control over institutions. At UCLA Med, the dominant vocabulary is merit, patient safety, diversity, holistic review, health equity, and public mission. These terms do not merely describe goals. They create a framework in which authority claims become inseparable from care itself. The school does not merely train doctors. It defines what a good doctor is and what kind of society medical education should reproduce. Whoever controls that definition controls the most powerful legitimating language available.
UCLA’s medical school presents itself as a leading public institution committed to scientific rigor, clinical excellence, and service to a diverse state. In practice it is a structured arena of elite competition organized around admissions committees, faculty departments, hospital leadership, UC-wide bureaucracy, and a growing legal-political battlefield that now includes the Department of Justice, Congress, outside advocacy groups, and national media. Rival coalitions do not reject the language of patient care or fairness. They compete to define what those words require, who has the authority to interpret them, and which institutional priorities should follow. What looks like debate over admissions criteria, curricular mission, or rankings is, underneath, a contest over who defines medical merit itself. That contest became explicit in May 2025, when Do No Harm, Students for Fair Admissions, and a rejected applicant sued UCLA’s medical school alleging unlawful race-conscious admissions. In January 2026, the Justice Department moved to join the suit, alleging a systemically racist approach and racial balancing. In February 2026, Judge John W. Holcomb granted the DOJ’s motion to intervene, formally nationalizing what had been a local professional dispute.
Three institutions concentrate this struggle more than any others. Clinical and educational authority, the admissions and selection system, and the reputation-funding-legitimacy network are UCLA Med’s master domains. Whoever governs them governs how future physicians are trained, who gets access to that training, and which definition of excellence prevails in a public institution under heavy external scrutiny.
The clinical and educational authority system is the first and most fundamental arena. The traditionalist-meritocratic coalition, concentrated among faculty physicians, outside physician groups, and the anti-DEI litigating bloc, uses the language of rigor, standards, competence, and patient safety. Its claim is that medicine is unforgiving, that admissions should rely heavily on MCAT scores and grades, and that relativizing those indicators risks producing weaker physicians and worse patient outcomes. The DOJ’s complaint cited median MCAT disparities across four entering classes, with Black and Latino matriculants averaging 506 to 509 against 513 to 516 for white and Asian American students. Whistleblowers alleged that admissions leadership required interview responses designed to surface race and used holistic review to confirm it. By framing traditional metrics as the best guardians of patient welfare and legal fairness, this coalition claims authority over the meaning of merit. The admissions dean who uses broader criteria is not experimenting with policy. In this telling, she risks patient safety and substitutes ideology for standards.
Turner’s essentialist diagnosis applies directly. The meritocratic coalition presents MCAT scores as stable, transparent measures of the qualities medicine most needs. But those indicators are institutional proxies, not essences. They have predictive value, and they also reflect unequal educational pathways, coaching, and social sorting. Their authority depends on the profession continuing to treat them as neutral enough to stabilize the pipeline. UCLA became controversial precisely because a rival coalition challenged that neutrality in practice.
The equity-and-mission coalition, concentrated among admissions leadership, diversity-oriented administrators, and public health faculty, uses the language of service, structural inequality, community need, and fairness through context. Its claim is that a good doctor is not merely a high-scoring test taker but someone capable of serving real populations in a large, diverse, unequal state. UCLA’s public posture in litigation has been procedural rather than ideological. It says the school follows federal and state anti-discrimination law while remaining committed to fair processes. The phrase holistic review does the central legitimating work. It allows the school to pursue non-metric criteria without conceding that it is abandoning merit. In this sense holistic does the same work that context and equity do elsewhere in elite institutions. It transforms a contested selection philosophy into a more humane vision of judgment.
Both coalitions claim access to what merit truly is. One locates it in standardized indicators and formal equality. The other locates it in broader capacities and mission fit. Neither presents its interpretation as interest. Both present it as necessity grounded in what medicine requires.
The admissions and selection system is the second master domain, now under direct federal assault. On February 24, 2026, just three days before the hearing on DOJ intervention in the admissions suit, the DOJ filed a separate eighty-one-page complaint against UCLA under Title VII, alleging that the university failed to protect Jewish and Israeli employees during the 2024 campus encampments and created a hostile work environment. The timing was not incidental. By hitting the university with Title VI and Title VII suits in the same month, the administration attempted a total jurisdictional siege, framing Chancellor Julio Frenk and Dean Jennifer Lucero as having presided over systemic discrimination across multiple protected categories at once. Critics such as Stanley Goldfarb of Do No Harm used the vocabulary of adult supervision, arguing that the essence of medical education has been poisoned by ideology and must be returned to its lifesaving mission. The administration’s coalition technology links these two suits through the language of institutional culture, arguing that the same leadership failures that produced one form of discrimination produced the other.
UCLA’s response has been to attempt categorical isolation, keeping the admissions suit separate from the employment suit and challenging the DOJ’s procedural standing. Under Title VI, the federal government is technically required to seek voluntary compliance before initiating litigation. UCLA’s legal team frames the DOJ as having used a neutral compliance review to launch a predetermined lawsuit without giving the school a fair chance to resolve matters informally. The jurisdictional move strips the federal government of moral authority before the merits are reached. UCLA is not yet arguing about MCAT scores. It is arguing that the process itself is illegitimate.
The reputation-funding-legitimacy network is the third master domain, and the one that makes the UCLA case especially unstable. The administration has suspended nearly $584 million in federal research grants, linking the freeze to both antisemitism allegations and alleged race-based admissions. UCLA’s professional-pragmatic bloc, composed of researchers and hospital physicians rather than admissions administrators, has responded by arguing that the DOJ’s litigation holds cancer research hostage and undermines American leadership in biomedicine. The language shifts the frame from campus culture to national competitiveness, making the costs of federal victory appear too high for the public to sustain. When a UCLA astrophysicist or oncologist speaks in national media about research disruption, he speaks not as an administrator defending a policy but as a scientist whose work is being held hostage by politics. The framing is identical to Harvard’s pivot from academic freedom to biotechnology leadership, and it recruits the same sympathetic audience.
That audience is not assembled by accident. UCLA benefits from a media and information infrastructure largely aligned with the professional-class institutions under federal attack. The New York Times, the Los Angeles Times, and higher education press consistently frame the DOJ intervention through the vocabulary UCLA prefers, emphasizing procedural overreach, student privacy, and the damage to research rather than the MCAT disparities the government emphasizes. Google’s search architecture, shaped by quality signals that privilege institutional and credentialed sources, systematically elevates coverage from these outlets over the commentary produced by Do No Harm, conservative legal blogs, or MAGA-adjacent media. The result is an information environment where the dominant public framing of the UCLA case treats federal intervention as aggression and UCLA’s resistance as principled defense of science and law. This is not a conspiracy. It is structural. The professional-class institutions that dominate credentialed media, search ranking, and platform moderation share the social world and epistemic assumptions of the institutions they cover. They do not need to coordinate to produce consistent framing. They simply apply their own standards of what counts as a reliable source, a serious argument, and a responsible outlet, and those standards happen to disadvantage the coalition attacking UCLA.
Pinsof’s framework makes the information infrastructure visible as a coalition technology. Every search result that ranks a Science or Nature editorial about research funding above a Do No Harm press release is a move in the jurisdictional contest. Every New York Times framing that leads with faculty concern about federal overreach rather than with MCAT score tables shifts the moral weight of the dispute. The administration’s coalition recognizes this, which is partly why its rhetoric targets mainstream media, elite universities, and Big Tech as a unified adversarial bloc. From the administration’s perspective, the information infrastructure does not merely report the conflict. It participates in it on UCLA’s side.
Turner’s analysis applies to both the legal and informational dimensions. Each side claims access to what the case truly is. The DOJ presents it as a civil rights enforcement action against an institution that evaded the Supreme Court’s mandate through euphemism and indirect racial proxies. UCLA presents it as a politicized assault on a public institution committed to serving California through lawful, mission-aligned processes. Both reconstruct the same legal materials, the same MCAT data, the same admissions files, to support incompatible conclusions. What is presented as the obvious reading in each case is the product of institutional work, coalition maintenance, and information management.
The case is now moving toward a jury trial set for June 2027, with a class certification hearing in November 2026. The discovery phase beginning in spring 2026 will produce federal subpoenas for internal communications, admissions training materials, and the specific weighting systems used in holistic review. UCLA’s admissions office, which has functioned as a relatively opaque internal body, will face the most invasive external scrutiny in the school’s history. Whether the holistic review process can survive that scrutiny while maintaining its legitimating function, the claim that it is both race-neutral and mission-serving, is the central question the litigation will force into the open.
The overall pattern holds. Every coalition claims authority by asserting possession of something essential. Traditionalists claim competence, legality, and patient safety. Equity actors claim justice, representation, and public mission. Metrics defenders claim fairness through objectivity. Holistic reviewers claim fairness through context. The federal government claims the authority of civil rights law and constitutional mandate. UCLA claims the authority of institutional expertise and public service. None presents its position as interest. All present it as necessity grounded in what medicine and law require.
What makes the UCLA case particularly illuminating in 2026 is that the fight has become public enough to expose the full machinery usually hidden behind institutional language. The masks have not just slipped inside committees and deans’ offices. They have slipped in federal court, in congressional hearings, in DOJ complaints, and in competing media ecosystems that now produce parallel realities about the same institution. UCLA is not merely defending a policy. It is defending its authority to define medical merit in a post-affirmative-action America, and it is doing so with the informational and institutional advantages of the professional-class coalition while its opponents try to delegitimize that coalition from outside it. The jurisdictional war continues through lawsuits, data mandates, frozen grants, and search rankings, determining who gets to say what a doctor is and who has the standing to make that definition stick.